Valdés S, García E, Pérez H, Hernández M

Language: English
References: 33
Page: 29-32
PDF size: 132.20 Kb.

ABSTRACT

Introduction Despite advances in diagnostic techniques and treatment, lung cancer is the leading cause of cancer death worldwide and in Cuba. Prompt initiation of cancer therapy depends on rapid diagnostic confirmation; however, most patients are diagnosed at an advanced stage. In the Cuban health system, primary, secondary and tertiary levels of care are interrelated; patients may seek care at any level or may be referred from one to another. Lung cancer diagnoses are confirmed at the tertiary level.
Objective Determine the length of diagnostic delay in patients diagnosed with non-small-cell lung cancer (NSCLC) at a tertiary care facility in Havana, Cuba, as well as mean diagnostic delay attributable to the patient and to the health system by level of care.
Methods A descriptive observational study of 96 patients with a cytologically and/or histologically confirmed diagnosis of non-small-cell lung cancer was conducted in 2005–2007. Patients initially sought care for disease symptoms at primary, secondary or tertiary levels in the Cuban public health system, but diagnosis of all patients was confirmed at a specialized tertiary care facility. Total diagnostic delay was calculated as the time elapsed from onset of symptoms to confirmation of NSCLC diagnosis. Variables also included diagnostic delay attributable to the patient and diagnostic delay attributable to the health system by level of care. Data were arranged in tables and analyzed by absolute value, percentage, mean, and standard deviation.
Results Of the 96 patients studied, 69% were male, and 54% were aged 50–69 years. Fifty-five percent of patients sought medical care within 15 days of onset of symptoms, 21% within 16–30 days, and 3% waited › 90 days. Mean diagnostic delay attributable to the patient was 18.19 ± 3.45 days while mean diagnostic delay attributable to the health system was 61.63 ± 18.50 days, and overall diagnostic delay was 73.13 ± 17.53 days. For the 71% of patients seen in primary care, mean diagnostic delay was 29.51 ± 4.53 days; for the 45% seen exclusively or additionally at the secondary level, mean diagnostic delay was 24.45 ± 7.31 days. Upon admission at the tertiary care level, mean diagnostic confirmation delay was 18.23 ± 3.68 days.
Conclusions Diagnostic delay of lung cancer patients in this study was prolonged. Appropriate strategies are needed for reducing this delay.

REFERENCES

1. Herbst R, Heymach J, Lippman S. Lung Cancer. N Engl J Med. 2008;359:1367–80.

2. Galán Y, Fernández L, Torres P, García M. Trends in Cuba’s Cancer Incidence (1990 to 2003) and Mortality (1990 to 2007). MEDICC Review. 2009;11(3):19–26.

3. Ministry of Public Health (CU), National Statistics Division. Anuario Estadístico de Salud 2007. Havana; 2008.

4. Moody A, Muers M, Forman D. Delays in managing lung cancer. Thorax. 2004 Jan;59(1):1–3.

5. Birring SS, Peake MD. Symptoms and the early diagnosis of lung cancer. Thorax. 2005 Apr;60(4):268–9.

6. Duménigo O, De Armas B, Gil A, Gordis MV. Nódulo pulmonar solitario: Qué hacer. Rev Cubana Cir [serial on the Internet]. 2007 Jun [cited 2008 Jan 26];46(2). Available from: http:// www.imbiomed.com.mx/1/1/articulos.php?id_ revista=57&id_ejemplar=4869

7. Sánchez I, Izquierdo JL, Almonacid C. Situación epidemiológica y pronóstica del cáncer de pulmón en nuestro medio. Arch Bronconeumol. 2006;42:594–9.

8. Cañizares MA, Rivo JE, Blanco M, Toscazo A, García EM, Purriños MJ. Influencia de la demora quirúrgica en la supervivencia de los pacientes intervenidos por carcinoma broncogénico. Arch Bronconeumol. 2007;43(3):165–70.

9. Ministry of Public Health (CU). Programa nacional de reducción de la mortalidad por cáncer. Havana; 1998.

10. National Oncology and Radiobiology Institute (CU). Cáncer de pulmón. Guía de diagnóstico y tratamiento. Havana; 2001.

11. Myrdal G, Lambe M, Hillerdal G, Lamberg K, Agustsson T, Ståhle E. Effect of delays on prognosis in patients with non-small-cell lung cancer. Thorax. 2004 Jan;59(1):45–9.

12. Van der Stuyft P, De Vos P. La relación entre los niveles de atención constituye un determinante clave de la salud. Rev Cubana Salud Pública [serial on the Internet]. 2008 Dec [cited 2009 May 22];34(4). Available from: http://scielo.sld. cu/scielo.php?script=sci_arttext&pid=S0864- 34662008000400014&lng=es&nrm=iso.

13. Rojas F. La Salud Pública Revolucionaria Cubana en su aniversario 50. Rev Cubana Salud Pública [serial on the Internet]. 2009 Mar [cited 2009 May 22];35(1). Available from: http://scielo. sld.cu/scielo.php?script=sci_arttext&pid=S0864- 34662009000100003&lng=es&nrm=iso.

14. National Cancer Control Unit (CU). Programa integral para el control del cáncer en Cuba. Pautas para la gestión. Vol. 1. Havana; 2009.

15. Torres AJ. Demora en el tratamiento quirúrgico del cáncer de pulmón. An Med Interna (Madrid). 2005 Aug;22(8):359–60.

16. Corner J, Hopkinson J, Fitzsimmons D. Is late diagnosis of lung cancer inevitable? Interview study of patients’ recollections of symptoms before diagnosis. Thorax. 2005 Apr;60(4):314–9.

17. Geddes DM. The natural history of lung cancer: a review based on tumour growth. Br J Dis Chest. 1979;73(1):1–17.

18. Booton R, Jones M, Thatcher N. Lung cancer 7: management of lung cancer in elderly patients. Thorax. 2003 Aug;58(8):711–20.

19. Porter JC, Spiro SG. Detection of early lung cancer. Thorax. 2000 Aug;55 Suppl 1:S56–62.

20. Jensen AR, Mainz J, Overgaard J. Delay on diagnosis and treatment of lung cancer. Lung cancer. 2002;37:227–8.

21. Ruiz Torrejón A, Ramos Montserrat MJ, Llobera Cánaves J. El médico de atención primaria y el diagnóstico de los pacientes con cáncer. Atención primaria. 2006;37(1):16–21.

22. Navarro J, Rodríguez R, Juanes A, Díaz F, Cabrera P. Tiempos de demora en el carcinoma broncogénico. Arch Bronconeumol. 2006;42(Espec Congr):85.

23. Cordovilla R, Serrano AR, González JM, Fernández JL, Moreno de Vega B, Ramos J, et al. Demoras diagnósticas en el cáncer de pulmón. Arch Bronconeumol. 2003 Oct;39(10):437–41.

24. Pajares V, Torrego A, Puzo MC, Plaza V, Bolivara I, Sanchos J. Resultados de la instrumentación de un programa de diagnóstico y tratamiento rápido del cáncer de pulmón. Arch Bronconeumol. 2007;43(Espec Congr):84.

25. Hamilton W, Sharp D. Diagnosis of lung cancer in primary care: a structure review. Fam Pract. 2004 Oct 1;21(6):605–11.

26. Monteagudo A, Romero RE, Salazar CE. Cáncer de pulmón, propuesta ética para agilizar su diagnóstico. Rev Hum Med [serial on the Internet]. 2007 Aug [cited 2008 Jan 22];7(2). Available from: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S1727-81202007000200004&lng= es&nrm=iso&tlng=es

27. Hirsh K, Gunnar H, Brandén E. Patient’s and doctor’s delays in the diagnosis of chest tumors. Lung cancer. 2002 Jan;35(1):53–7.

28. Monteagudo A, Mora A, García O. Las relaciones ciencia-tecnología-sociedad en el diagnóstico temprano del cáncer del pulmón. Rev Hum Med [serial on the Internet]. 2004 Aug [cited 2008 Jan 22];4(2). Available from: http://scielo.sld. cu/scielo.php?script=sci_issuetoc&pid=1727- 812020040002&lng=es&nrm=iso

29. Gómez F, Casitas R, García M. Implantación de una consulta protocolizada de diagnóstico rápido de cáncer de pulmón. Arch Bronconeumol. 2006;42(Espec Congr):80.

30. Valdivia M, Martínez J, Guillamón M, Sánchez J, de la Torre J, Santacruz A. Tiempo empleado en el diagnóstico y estadiaje de tumores torácicos. Arch Bronconeumol. 2007;43(Espec Congr):86.

31. Dische S, Gidson D, Parmar D, Saunders MI. Timer course from first symptom to treatment in patient with non-small-cell lung cancer referred for radiotherapy, a report by CHART steering committee. Thorax. 1996 Dec;51(12):1262–5.

32. González JM, de Castro F, Barrueco M, Cordobilla R, Fernández J, Gómez FP. Demoras diagnósticas en el cáncer de pulmón. Arch Bronconeumol. 2003;39:437–41.

33. Carbone P. Lung Cancer: Early Events, Early Interventions: Conference Summary for the 46th Annual Thomas L. Petty Aspen Lung Conference. Chest. 2004 May;125(5):167–72.